Hainan to promote drug import facilitation
Recently, the thirty-eighth meeting of theStanding Committee of the Sixth People's Congress of Hainan Province consideredand adopted the "Hainan Free Trade Port drug import facilitation provisions.
First, it is clear that the import ofdrugs from the designated import port of Hainan Free Trade Port drug imports,should be filed to the port of drug supervision and management departments,without the "import drug clearance".
Second, the port location of drugsupervision and management departments received the application materials forthe record of imported drugs, after review that the materials submitted by theimported drug companies meet the filing requirements, the same day to completethe import filing procedures, and the filing of electronic information exchangeto the Customs and Excise Department, while informing imported drug companiesof the record results. Approved for the record of imported drug companiesshould be customs clearance procedures.
Third, the provisions of the portlocation of drug supervision and management departments should be based on theneeds of imported drug enterprises, free of charge for enterprises to providecustoms clearance certificates for imported drugs.
Fourth, drug supervision and managementdepartments should strengthen the circulation of imported drugs, the use ofsupervision and management, sampling and inspection, the establishment ofimported drugs, corporate credit files, bad credit records of imported drugcompanies, increase the frequency of supervision and inspection, and relevantdepartments to implement joint discipline according to law.
Fifth, emphasizing the mainresponsibility of the enterprise, the enterprise of imported drugs shouldestablish and implement the management system of imported drug informationtraceability, pharmacovigilance, etc., to comply with the requirements of theCode of Good Manufacturing Practice, to ensure the quality and safety ofimported drugs and traceability.
Looking for chemical products? Let suppliers reach out to you!
2026-06-20
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
Biocytogen announces the launch of the 'Nano 100 Project' to develop fully human therapeutic nanobodies against 100+ targets
-
Wantai Biotech 20-valent pneumonia vaccine started clinical trials, how far is domestic substitution?
-
Yiming Cell 'Suspension 293XS Cell Bank' completed DMF filing with the US FDA
-
The phase III clinical study of Junshi Biologics in combination with teripulimab in the treatment of advanced triple-negative breast cancer reached the primary endpoint
-
The next bombshell: 'PD-1 + ADC', Kelun, Hengrui are going to win numbness?
-
L-Rotator Biotech completed its pre-A financing and continued to increase its investment in the CGT field
-
Enable the 'export of EU APIcertification documents' and 'pharmaceutical export salescertificate' electronic proof
-
China to focus on building quality and efficient TCM service system in next five years
-
Overwhelming influx of alliance procurement: orthopaedics and IOLs
Recommend Reading
-
J&J VAT Dispute Threatens Free Medicine Access in Britain
-
Pfizer Warns Germany: Drug Pricing Could Put Investment at Risk
-
Pfizer Lifts 2025 Profit Forecast After Q2 Earnings Beat Sales Hit $14.65 Billion Shares Jump 2.8 Percent
-
Sandoz Set to Slash Canadian Weight-loss Drug Prices by Up to 70 Percent Generics Could Expand Patient Access
-
4 Pharma Firms Lose Licenses in Jammu and Kashmir Amid Illegal Drug Sales Crackdown
-
Lithium carbonate shows rollercoaster market trend, upward signal may appear
-
1 Million Ton Green Methanol Project Signed in Fujian with 15 Billion Yuan Investment Global Partners Set Sights on Clean Energy Chain
-
LANXESS Launches ISCC PLUS-Certified Version of Additin RC 2515 Lubricant Additive
-
Ammonium Sulfate Market Prices Show a Small Increase (11.8-11.14)
-
Multiple Negative Factors Weigh on Styrene, Driving Prices Lower